z-logo
open-access-imgOpen Access
Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days after Administration
Author(s) -
Elizabeth Weesner,
Hosain Ghassemi,
Iryna Salapenka,
Jaya Sri Konakanchi,
Gregory F. Maggio,
Roopa Sethi
Publication year - 2022
Publication title -
kansas journal of medicine
Language(s) - English
Resource type - Journals
ISSN - 1948-2035
DOI - 10.17161/kjm.vol15.17931
Subject(s) - buprenorphine , opioid use disorder , opioid , extended release , anesthesia , medicine , administration (probate law) , pharmacology , narcotic antagonists , (+) naloxone , political science , receptor , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here